Table 1. Basic demographic and clinical data for the EVT and non-EVT groups.
| EVT (n = 56, 35.9%) | Non-EVT (n = 100, 64.1%) | p value | |
|---|---|---|---|
| Female | 32 (57.1%) | 64 (64.0%) | 0.493 |
| Age (SD), years | 84.1 (3.38) | 85.0 (4.50) | 0.159 |
| Past history | |||
| Smoking | 10 (17.9%) | 23 (23.0%) | 0.542 |
| Stroke | 16 (28.6%) | 32 (32.0%) | 0.720 |
| Hypertension | 35 (62.5%) | 63 (63.0%) | 1.000 |
| Diabetes mellitus | 13 (23.2%) | 18 (18.0%) | 0.531 |
| Hyperlipidemia | 3 (5.4%) | 8 (8.0%) | 0.747 |
| Atrial fibrillation | 23 (41.1%) | 26 (26.0%) | 0.072 |
| Coronary heart disease | 10 (17.9%) | 8 (8.0%) | 0.073 |
| Prestroke mRS score | 0.423 | ||
| 0 | 45 (80.4%) | 72 (72.0%) | |
| 1 | 5 (8.9%) | 16 (16.0%) | |
| 2 | 6 (10.7%) | 12 (12.0%) | |
| Occlusion site | 0.478 | ||
| Internal carotid | 10 (17.8%) | 24 (24.0%) | |
| Middle cerebral | 37 (66.1%) | 67 (67.0%) | |
| Basilar | 7 (12.5%) | 6 (6.0%) | |
| Vertebral | 2 (3.6%) | 3 (3.0%) | |
| TOAST classification | 0.146 | ||
| Large artery atherosclerosis | 12 (21.4%) | 34 (34.0%) | |
| Cardioembolism | 38 (67.9%) | 50 (50%) | |
| Small artery occlusion | - | - | |
| Other cause | 0 (0%) | 2 (2.0%) | |
| Undetermined cause | 6 (10.7%) | 14 (14.0%) | |
| Time from onset | 0.606 | ||
| < 3 hours | 37 (66.1%) | 61 (61.0%) | |
| 3-8 hours | 19 (33.9%) | 39 (39.0%) | |
| Initial NIHSS score (SD) | 14.2 (7.57) | 14.6 (7.84) | 0.763 |
| Intravenous tPA use | 35 (62.5%) | 60 (60.0%) | 0.864 |
EVT = endovascular treatment; mRS = modified Rankin scale; NIHSS = National Institute of Health Stroke Scale; SD = standard deviation; TOAST = Trial of Org 10172 Acute Stroke Treatment; tPA = tissue plasminogen activator